loadpatents
name:-0.083923101425171
name:-0.012926816940308
name:-0.0043730735778809
Sakai; Yoshiki Patent Filings

Sakai; Yoshiki

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sakai; Yoshiki.The latest application filed is for "disease-site-specific liposomal formulation".

Company Profile
2.11.17
  • Sakai; Yoshiki - Osaka JP
  • Sakai; Yoshiki - Kobe-shi JP
  • Sakai; Yoshiki - Suita-shi Osaka
  • Sakai; Yoshiki - Tokyo JP
  • Sakai; Yoshiki - Suita JP
  • Sakai; Yoshiki - Sasayama JP
  • Sakai; Yoshiki - Hyogo JP
  • Sakai; Yoshiki - Sasayama-shi JP
  • Sakai; Yoshiki - Mishima-gun JP
  • Sakai; Yoshiki - Mishimagun JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Disease-site-specific Liposomal Formulation
App 20210113464 - Sawa; Yoshiki ;   et al.
2021-04-22
Medicinal Composition for Treating Intractable Heart Disease
App 20200360391 - Sawa; Yoshiki ;   et al.
2020-11-19
Medicinal Composition for Treating Intractable Heart Disease
App 20190343841 - Sawa; Yoshiki ;   et al.
2019-11-14
System And Method For Information Processing
App 20180357669 - Tokuhisa; Shinya ;   et al.
2018-12-13
Drug-eluting stent graft
Grant 9,968,716 - Sawa , et al. May 15, 2
2018-05-15
Advanced heart failure treatment material as myocardial/cardiovascular regeneration device
Grant 9,597,436 - Sawa , et al. March 21, 2
2017-03-21
Drug-eluting Stent Graft
App 20160250395 - Sawa; Yoshiki ;   et al.
2016-09-01
Pulmonary Disease-specific Therapeutic Agent
App 20150272874 - Sawa; Yoshiki ;   et al.
2015-10-01
Advanced Heart Failure Treatment Material as Myocardial/Cardiovascular Regeneration Device
App 20150231312 - Sawa; Yoshiki ;   et al.
2015-08-20
Endogeneous repair factor production accelerators
Grant 8,642,630 - Sakai , et al. February 4, 2
2014-02-04
Sustained release preparation for tissue regeneration therapy
Grant 8,617,614 - Sakai , et al. December 31, 2
2013-12-31
Endogeneous Repair Factor Production Accelerators
App 20130225643 - SAKAI; Yoshiki ;   et al.
2013-08-29
Endogeneous repair factor production promoters
Grant 8,436,026 - Sakai , et al. May 7, 2
2013-05-07
Percutaneous Absorption Preparation
App 20110071204 - Takahashi; Koichi ;   et al.
2011-03-24
Sustained Release Preparation For Tissue Regeneration Therapy
App 20100323026 - Sakai; Yoshiki ;   et al.
2010-12-23
Therapeutic agent for type II diabetes comprising protease-inhibiting compound
Grant 7,671,057 - Sakai March 2, 2
2010-03-02
Adhesive preparation
App 20090239828 - Yamazaki; Yuuhiro ;   et al.
2009-09-24
Endogenous repair factor production accelerator
Grant 7,547,715 - Sakai , et al. June 16, 2
2009-06-16
Endogeneous Repair Factor Production Promoters
App 20080299089 - SAKAI; Yoshiki ;   et al.
2008-12-04
Therapeutic Agent for Diabetes Comprising Protease-Inhibiting Compound
App 20080009537 - Sakai; Yoshiki
2008-01-10
Transdermal absorption preparation
App 20060188554 - Nakashima; Katashi ;   et al.
2006-08-24
Agentfor reducing side effects of diclofenac
App 20060122275 - Sakai; Yoshiki ;   et al.
2006-06-08
Endogenous repair factor production promoters
App 20060069018 - Sakai; Yoshiki ;   et al.
2006-03-30
Medicinal compositions comprising diclofenac and ornoprostil
App 20040068014 - Sakai, Yoshiki ;   et al.
2004-04-08
Use of prostaglandin analogues to treat cytodamage
Grant 4,503,068 - Sakai , et al. March 5, 1
1985-03-05
Use of prostaglandin analogues to treat cytodamage
Grant 4,464,388 - Sakai , et al. August 7, 1
1984-08-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed